Skip to main content

Table 4 Summary of key measurement properties of the EoE-IQ at baseline and week 24

From: Validation of the novel Eosinophilic Esophagitis Impact Questionnaire

Measurement property

Baseline

Week 24

Construct validity: convergent and divergent validity

Pearson correlation coefficient (n) at baseline/week 24

DSQ

0.44 (224)

0.68 (175)

 

EoE-SQ Frequency

0.56 (224)

0.72 (212)

 

EoE-SQ Severity

0.54 (224)

0.61 (212)

 

PGIS

0.60 (224)

0.67 (212)

 

EoE-EREFS

–0.10 (224)

0.20 (207)

 

Peak esophageal intraepithelial eosinophil count

Not conducteda

0.15 (208)

 

Categorized peak esophageal intraepithelial eosinophil count

Not conducteda

0.09 (208)

Construct validity: known-groups validity

Mean score (n) per known group at baseline/week 24

PGIS

None: 1.09 (1)

None: 1.15 (66)

  

Mild: 1.82 (99)

Mild: 1.52 (107)

  

Moderate: 2.52 (104)

Moderate: 2.29 (32)

  

Severe: 3.25 (20)

Severe: 2.99 (7)

  

P < 0.0001

P < 0.0001

 

Categorized peak esophageal intraepithelial eosinophil count

≤ 6 eos/hpf: not conducteda

≤ 6 eos/hpf: 1.49 (97)

  

> 6 to < 15 eos/hpf: not conducteda

> 6 to < 15 eos/hpf: 1.54 (30)

  

≥ 15 eos/hpf: not conducteda

≥ 15 eos/hpf: 1.61 (81)

  

P = not conducteda

P = 0.4556

Ability to detect change: responsiveness and interpretation of change

EoE-IQ change by PGIS change between baseline and week 24

Mean change score (n)

Improved: –0.863 (121)

  

No change: − 0.394 (65)

  

Worsened: 0.062 (12)

  

P < 0.0001

EoE-IQ change by PGIC at week 24

Mean change score (n)

Better: − 0.780 (160)

  

No change: − 0.231 (29)

  

Worse: 0.251 (9)

  

P < 0.0001

Pearson correlation of change coefficient (n) at week 24

DSQ

0.46 (162)

 

EoE-SQ Frequency

0.53 (198)

 

EoE-SQ Severity

0.42 (198)

 

PGIS

0.55 (198)

 

PGIC

0.44 (198)

 

EoE-EREFS

0.04 (194)

 

Peak esophageal intraepithelial eosinophil count

0.07 (195)

 

Categorized peak esophageal intraepithelial eosinophil count

0.03 (195)

  1. DSQ, Dysphagia Symptom Questionnaire; EoE-EREFS, Eosinophilic Esophagitis Endoscopic Reference Score; EoE-IQ, Eosinophilic Esophagitis Impact Questionnaire; EoE-SQ, Eosinophilic Esophagitis Symptom Questionnaire; eos/hpf, eosinophils per high-power field; PGIC, Patient Global Impression of Change; PGIS, Patient Global Impression of Severity
  2. aAnalysis not conducted because the study inclusion criteria required patients to have eos/hpf ≥ 15 at baseline, thereby limiting the dynamic range of scores